BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 27789395)

  • 1. Generation of a gene-corrected isogenic control hiPSC line derived from a familial Alzheimer's disease patient carrying a L150P mutation in presenilin 1.
    Poon A; Schmid B; Pires C; Nielsen TT; Hjermind LE; Nielsen JE; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):466-469. PubMed ID: 27789395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
    Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
    Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Derivation of induced pluripotent stem cells from a familial Alzheimer's disease patient carrying the L282F mutation in presenilin 1.
    Poon A; Li T; Pires C; Nielsen TT; Nielsen JE; Holst B; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Nov; 17(3):470-473. PubMed ID: 27789396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying an A79V mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):229-32. PubMed ID: 27345973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a L150P mutation in PSEN-1.
    Tubsuwan A; Pires C; Rasmussen MA; Schmid B; Nielsen JE; Hjermind LE; Hall V; Nielsen TT; Waldemar G; Hyttel P; Clausen C; Kitiyanant N; Freude KK; Holst B
    Stem Cell Res; 2016 Jan; 16(1):110-2. PubMed ID: 27345792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation of induced pluripotent stem cells (iPSCs) from an Alzheimer's disease patient carrying a M146I mutation in PSEN1.
    Li T; Pires C; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Dinnyes A; Holst B; Hyttel P; Freude KK
    Stem Cell Res; 2016 Mar; 16(2):334-7. PubMed ID: 27345998
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of two isogenic iPSC lines with either a heterozygous or a homozygous E280A mutation in the PSEN1 gene.
    Frederiksen HR; Holst B; Mau-Holzmann UA; Freude K; Schmid B
    Stem Cell Res; 2019 Mar; 35():101403. PubMed ID: 30769329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of induced pluripotent stem cell line (ZZUi009-A) from an Alzheimer's disease patient carrying a PSEN1 gene mutation.
    Wang Y; Jing N; Su L; Shi C; Zhang P; Wang Z; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2018 Mar; 27():30-33. PubMed ID: 29304399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generation of an isogenic, gene-corrected iPSC line from a symptomatic 59-year-old female patient with frontotemporal dementia caused by an R406W mutation in the microtubule associated protein tau (MAPT) gene.
    Nimsanor N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
    Stem Cell Res; 2016 Nov; 17(3):576-579. PubMed ID: 27934586
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation of an integration-free iPSC line, ICCSICi006-A, derived from a male Alzheimer's disease patient carrying the PSEN1-G206D mutation.
    Díaz-Guerra E; Oria-Muriel MA; Moreno-Jiménez EP; de Rojasb I; Rodríguez C; Rodríguez-Traver E; Orera M; Hernándezb I; Ruizb A; Vicario C
    Stem Cell Res; 2019 Oct; 40():101574. PubMed ID: 31627126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of one iPSC line (IMEDEAi006-A) from an early-onset familial Alzheimer's Disease (fAD) patient carrying the E280A mutation in the PSEN1 gene.
    Vallejo-Diez S; Fleischer A; Martín-Fernández JM; Sánchez-Gilabert A; Castresana M; Aguillón D; Villegas A; Mastronardi CA; Espinosa LG; Arcos-Burgos M; Del Pozo Á; Herrán E; Gainza E; Isaza-Ruget M; Lopera F; Bachiller D
    Stem Cell Res; 2019 May; 37():101440. PubMed ID: 31026686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of an isogenic, gene-corrected iPSC line from a pre-symptomatic 28-year-old woman with an R406W mutation in the microtubule associated protein tau (MAPT) gene.
    Nimsanor N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
    Stem Cell Res; 2016 Nov; 17(3):600-602. PubMed ID: 27934590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of a human induced pluripotent stem cell line from a familial Alzheimer's disease PSEN1 T119I patient.
    Isaja L; Rodríguez-Varela MS; Marazita M; Mucci S; Itzcovich T; Chrem-Méndez P; Niikado M; Ferriol-Laffouillere SL; Allegri R; Martinetto H; Sevlever GE; Scassa ME; Surace EI; Romorini L
    Stem Cell Res; 2021 May; 53():102325. PubMed ID: 33839546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of induced pluripotent stem cell line (ZZUi010-A) from an Alzheimer's disease patient carrying an APP gene mutation.
    Wang Z; Zhang P; Wang Y; Shi C; Jing N; Sun H; Yang J; Liu Y; Wen X; Zhang J; Zhang S; Xu Y
    Stem Cell Res; 2017 Dec; 25():213-216. PubMed ID: 29156377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced pluripotent stem cells from familial Alzheimer's disease patients differentiate into mature neurons with amyloidogenic properties.
    Mahairaki V; Ryu J; Peters A; Chang Q; Li T; Park TS; Burridge PW; Talbot CC; Asnaghi L; Martin LJ; Zambidis ET; Koliatsos VE
    Stem Cells Dev; 2014 Dec; 23(24):2996-3010. PubMed ID: 25027006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of an isogenic, gene-corrected iPSC line from a symptomatic 57-year-old female patient with frontotemporal dementia caused by a P301L mutation in the microtubule associated protein tau (MAPT) gene.
    Nimsanor N; Kitiyanant N; Poulsen U; Rasmussen MA; Clausen C; Mau-Holzmann UA; Nielsen JE; Nielsen TT; Hyttel P; Holst B; Schmid B
    Stem Cell Res; 2016 Nov; 17(3):556-559. PubMed ID: 27789409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. iPSCs-derived nerve-like cells from familial Alzheimer's disease PSEN 1 E280A reveal increased amyloid-beta levels and loss of the Y chromosome.
    Mendivil-Perez M; Velez-Pardo C; Kosik KS; Lopera F; Jimenez-Del-Rio M
    Neurosci Lett; 2019 Jun; 703():111-118. PubMed ID: 30904577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of induced pluripotent stem cells (IRMBi001-A) from an Alzheimer's disease patient carrying a G217D mutation in the PSEN1 gene.
    Auboyer L; Monzo C; Wallon D; Rovelet-Lecrux A; Gabelle A; Gazagne I; Cacheux V; Lehmann S; Crozet C
    Stem Cell Res; 2019 Jan; 34():101381. PubMed ID: 30677723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H271.
    Marthaler AG; Schmid B; Tubsuwan A; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen JE; Nielsen TT; Holst B
    Stem Cell Res; 2016 Jan; 16(1):180-3. PubMed ID: 27345809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of an isogenic, gene-corrected control cell line of the spinocerebellar ataxia type 2 patient-derived iPSC line H196.
    Marthaler AG; Schmid B; Tubsuwan A; Poulsen UB; Engelbrecht AF; Mau-Holzmann UA; Hyttel P; Nielsen JE; Nielsen TT; Holst B
    Stem Cell Res; 2016 Jan; 16(1):162-5. PubMed ID: 27345804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.